SCHEMBL3785148

SCHEMBL3785148

CC(=O)SOc1ccccc1-c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4E B2RXH2 3/20 0.36
FABP3 P05413 2/20 0.36
PGR P06401 1/20 0.36
FABP7 O15540 1/20 0.36
FABP5 Q01469 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3794457 0.89 NCOA1 (0.38) NCOA1NCOA3PTGDR2SLC6A4SLC6A3
SCHEMBL3791104 0.84 ALDH1A1 (0.39) PTGDR2ALDH1A1SMN1; SMN2TUBB4ATUBB
SCHEMBL3792049 0.84 PTGDR2 (0.47) PTGDR2ALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL3789776 0.83 ADRA2A (0.43) L3MBTL1KDM4EALDH1A1TUBB4ATUBB
SCHEMBL3790313 0.83 NCOA1 (0.41) NCOA1NCOA3PTGDR2TDP1L3MBTL1
SCHEMBL3794925 0.82 ALDH1A1 (0.43) TDP1L3MBTL1ALDH1A1SMN1; SMN2SCN9A
SCHEMBL3786324 0.81 PTGDR2 (0.48) NCOA1NCOA3PTGDR2TDP1L3MBTL1
SCHEMBL3780508 0.81 PTGDR2 (0.58) NCOA1NCOA3PTGDR2ALDH1A1TUBB4A
SCHEMBL3790378 0.80 NCOA1 (0.49) NCOA1NCOA3TDP1KDM4EFABP3
SCHEMBL3786673 0.78 MTOR (0.32) TDP1KDM4EALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 NCOA1 2120/4885NCOA3 989/4885PTGDR2 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.